VYGR CIK: 1640266

Voyager Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−53.5
FY22:
−12.5
FY23:
77.9
FY24:
−15.3
FY25:
−132
Change from FY21 to FY25
millions USD
FY21:
65.9
FY22:
−7.34
FY23:
−142
FY24:
−94.9
FY25:
125
Change from FY21 to FY25
millions USD
FY21:
0.61
FY22:
1.11
FY23:
33.6
FY24:
114
FY25:
0.82
millions USD
FY21:
13.0
FY22:
−18.7
FY23:
−30.1
FY24:
3.85
FY25:
−6.21
(positive)
Change from FY21 to FY25
millions USD
FY21:
−55.1
FY22:
−15.0
FY23:
74.7
FY24:
−18.8
FY25:
−135

All amounts in millions USD Data source:SEC EDGAR